231 related articles for article (PubMed ID: 24197117)
1. The SmgGDS splice variant SmgGDS-558 is a key promoter of tumor growth and RhoA signaling in breast cancer.
Hauser AD; Bergom C; Schuld NJ; Chen X; Lorimer EL; Huang J; Mackinnon AC; Williams CL
Mol Cancer Res; 2014 Jan; 12(1):130-42. PubMed ID: 24197117
[TBL] [Abstract][Full Text] [Related]
2. SmgGDS regulates cell proliferation, migration, and NF-kappaB transcriptional activity in non-small cell lung carcinoma.
Tew GW; Lorimer EL; Berg TJ; Zhi H; Li R; Williams CL
J Biol Chem; 2008 Jan; 283(2):963-76. PubMed ID: 17951244
[TBL] [Abstract][Full Text] [Related]
3. SmgGDS is a guanine nucleotide exchange factor that specifically activates RhoA and RhoC.
Hamel B; Monaghan-Benson E; Rojas RJ; Temple BR; Marston DJ; Burridge K; Sondek J
J Biol Chem; 2011 Apr; 286(14):12141-8. PubMed ID: 21242305
[TBL] [Abstract][Full Text] [Related]
4. The Tumor-suppressive Small GTPase DiRas1 Binds the Noncanonical Guanine Nucleotide Exchange Factor SmgGDS and Antagonizes SmgGDS Interactions with Oncogenic Small GTPases.
Bergom C; Hauser AD; Rymaszewski A; Gonyo P; Prokop JW; Jennings BC; Lawton AJ; Frei A; Lorimer EL; Aguilera-Barrantes I; Mackinnon AC; Noon K; Fierke CA; Williams CL
J Biol Chem; 2016 Mar; 291(12):6534-45. PubMed ID: 26814130
[TBL] [Abstract][Full Text] [Related]
5. Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoC.
Wu D; Asiedu M; Wei Q
Oncogene; 2009 Jun; 28(22):2219-30. PubMed ID: 19421144
[TBL] [Abstract][Full Text] [Related]
6. SmgGDS-558 regulates the cell cycle in pancreatic, non-small cell lung, and breast cancers.
Schuld NJ; Hauser AD; Gastonguay AJ; Wilson JM; Lorimer EL; Williams CL
Cell Cycle; 2014; 13(6):941-52. PubMed ID: 24552806
[TBL] [Abstract][Full Text] [Related]
7. Splice switching an oncogenic ratio of SmgGDS isoforms as a strategy to diminish malignancy.
Brandt AC; McNally L; Lorimer EL; Unger B; Koehn OJ; Suazo KF; Rein L; Szabo A; Tsaih SW; Distefano MD; Flister MJ; Rigo F; McNally MT; Williams CL
Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3627-3636. PubMed ID: 32019878
[TBL] [Abstract][Full Text] [Related]
8. RhoGDIα-dependent balance between RhoA and RhoC is a key regulator of cancer cell tumorigenesis.
Giang Ho TT; Stultiens A; Dubail J; Lapière CM; Nusgens BV; Colige AC; Deroanne CF
Mol Biol Cell; 2011 Sep; 22(17):3263-75. PubMed ID: 21757538
[TBL] [Abstract][Full Text] [Related]
9. Rho isoform-specific interaction with IQGAP1 promotes breast cancer cell proliferation and migration.
Casteel DE; Turner S; Schwappacher R; Rangaswami H; Su-Yuo J; Zhuang S; Boss GR; Pilz RB
J Biol Chem; 2012 Nov; 287(45):38367-78. PubMed ID: 22992742
[TBL] [Abstract][Full Text] [Related]
10. RhoA and RhoC differentially modulate estrogen receptor α recruitment, transcriptional activities, and expression in breast cancer cells (MCF-7).
Malissein E; Meunier E; Lajoie-Mazenc I; Médale-Giamarchi C; Dalenc F; Doisneau-Sixou SF
J Cancer Res Clin Oncol; 2013 Dec; 139(12):2079-88. PubMed ID: 24096540
[TBL] [Abstract][Full Text] [Related]
11. Structure-based analysis of the guanine nucleotide exchange factor SmgGDS reveals armadillo-repeat motifs and key regions for activity and GTPase binding.
Shimizu H; Toma-Fukai S; Saijo S; Shimizu N; Kontani K; Katada T; Shimizu T
J Biol Chem; 2017 Aug; 292(32):13441-13448. PubMed ID: 28630045
[TBL] [Abstract][Full Text] [Related]
12. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
[TBL] [Abstract][Full Text] [Related]
13. Splice variants of SmgGDS control small GTPase prenylation and membrane localization.
Berg TJ; Gastonguay AJ; Lorimer EL; Kuhnmuench JR; Li R; Fields AP; Williams CL
J Biol Chem; 2010 Nov; 285(46):35255-66. PubMed ID: 20709748
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
[TBL] [Abstract][Full Text] [Related]
15. IκB kinase γ/nuclear factor-κB-essential modulator (IKKγ/NEMO) facilitates RhoA GTPase activation, which, in turn, activates Rho-associated KINASE (ROCK) to phosphorylate IKKβ in response to transforming growth factor (TGF)-β1.
Kim HJ; Kim JG; Moon MY; Park SH; Park JB
J Biol Chem; 2014 Jan; 289(3):1429-40. PubMed ID: 24240172
[TBL] [Abstract][Full Text] [Related]
16. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.
Wang L; Yang L; Luo Y; Zheng Y
J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257
[TBL] [Abstract][Full Text] [Related]
17. Divergence of Rho residue 43 impacts GEF activity.
Sloan CM; Quinn CV; Peters JP; Farley J; Goetzinger C; Wernli M; DeMali KA; Ellerbroek SM
Small GTPases; 2012; 3(1):15-22. PubMed ID: 22673745
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of the unique guanine nucleotide exchange factor, SmgGDS, in vascular smooth muscle cells.
Thill R; Campbell WB; Williams CL
J Cell Biochem; 2008 Aug; 104(5):1760-70. PubMed ID: 18348285
[TBL] [Abstract][Full Text] [Related]
19. A p27(kip1)-binding protein, p27RF-Rho, promotes cancer metastasis via activation of RhoA and RhoC.
Hoshino D; Koshikawa N; Seiki M
J Biol Chem; 2011 Jan; 286(4):3139-48. PubMed ID: 21087931
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma.
Horiuchi A; Imai T; Wang C; Ohira S; Feng Y; Nikaido T; Konishi I
Lab Invest; 2003 Jun; 83(6):861-70. PubMed ID: 12808121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
